Study S001589

Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation (SPICE-AF)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07389941
Acronym: SPICE-AF
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: NOT_YET_RECRUITING
Enrollment: 240
Start: 2026-10
Primary completion: 2029-04
Lead sponsor: University of Luebeck
Conditions: Atrial Fibrillation (AF)
Interventions: DRUG:Semaglutide (SEMA)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Freedom from atrial arrhythmia (AF/atrial flutter/atrial tachycardia >30 sec) at 12 months post-ablation (8-week-blanking period) [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.